ABCDEFGHIJKLMNOPQRSTUVWXYZAAABACADAEAFAGAH
1
Labs or Groups by researcher name [lead] added when individuals have research staffEmail / ChipLead / PI name(s) and bio linkSchool / CollegeDepartment / SubunitFocus of ResearchProgram Area(s)Video(s)Experts@MinnesotaAdditional LinksMCC Leadership Link (if applicable)
2
Adamala (Kate) Lab - Prototyping Biology Kate AdamalaKate Adamala, PhDBiological SciencesGenetics, Cell Biology, and Development
Building semi-synthetic minimal cellsGenetic Mechanismsadama009@umn.eduhttps://experts.umn.edu/en/persons/kate-adamala
3
Advanced Research and Diagnostics Laboratory (ARDL, primary group)Anna Prizment Bharat ThyagarajanAnna Prizment, PhD
Bharat Thyagarajan, MD, PhD, MPH		Medical SchoolLaboratory Medicine and PathologyAP: chronic disease epidemiologist who studies blood, tissue, and genetic biomarkers in cancer, dementia and other age-related diseases
BT: genetic susceptibility to breast cancer. I am also interested in studying the role of DNA repair pathways in determining outcomes after chemotherapy and hematopoietic cell transplants		"Screening, Prevention, Etiology and Cancer Survivorship", Genetic Mechanisms
4
Aihara (Hideki) [lead]aihar001@umn.eduHideki Aihara, PhDBiological SciencesBiochemistry, Molecular Biology, and Biophysicshow cancer-causing mutations are introduced by the APOBEC3B cytosine deaminase. Our approach is to use x-ray cyrstallography and elucidate three-dimensional structure of the enzyme and enzyme-DNA complexesGenetic Mechanisms
5
Aksan (Alptekin) BioGelLabsaaksan@umn.eduAlptekin Aksan, PhDScience and EngineeringMechanical Engineeringcapabilities of biologicals with synthetic materials to make new reactive materials with novel propertiesCellular MechanismsAlptekin Aksan
6
Alam (Amer) Structural Biology of Membrane Transportaalam@umn.eduAmer Alam, PhD
Research & Innovation Office
The Hormel Institutemembrane transport proteins whose dysfunction leads to aberrant peroxisomal functioning and biogenesis and its subsequent effect on cancer progression through aberrant metabolic functions and evasion immune responseCellular Mechanisms
7
Aliota (Matthew) Labmtaliota@umn.eduMatthew Aliota, PhDVeterinary MedicineVeterinary and Biomedical Sciencesways that viruses evolve within individual hosts, and during transmission to new hosts, to do things like evade detection from innate and adaptive immunity or acquire the ability to infect new cell, tissue, and host typesGenetic Mechanisms
8
Allen (Sharon) [lead]allen001@umn.eduSharon Allen, MD, PhDMedical SchoolFamily Medicine and Community HealthTobacco cessation research; with specific interest in effects of menopause and menstrual cycle on smoking cessation in women, additional interest in smokeless tobacco cessation and CV risk"Screening, Prevention, Etiology and Cancer Survivorship"
9
Allred (Jeremy) Laballred@umn.eduJeremy Allred, MDMedical SchoolMedicineImmunology of Cancer, Bone Marrow Transplant and Cellular Therapy, Immune Therapy, Stem Cell Biology, Developmental HematopoiesisTransplant and Cellular Therapy
10
Analytical Biochemistry Shared Resourcevilla001@umn.eduPeter Villalta, PhDOffice of Academic Clinical AffairsCancer Centermass spectrometric measurement of trace constituents of biological fluids and tissues. My research interests involve using this expertise to measure levels of various compounds upon exposure of the body to carcinogensCarcinogenesis and Chemoprevention
11
Arriaga (Edgar) Organelle Research GroupEdgar ArriagaEdgar Arriaga, PhD Science and EngineeringChemistry​
12
Artinger (Kristin) labkartinge@umn.eduKristin Artinger, PhDDentistryResearch and Discoverymolecular and genetic mechanisms involved in the development of the neural crestCellular Mechanisms
13
Asakura (Atsushi) Lab asakura@umn.eduAtsushi Asakura, PhDMedical SchoolNeurologymolecular mechanisms controlling muscle satellite cell (muscle stem cell) self-renewal and differentiation, Duchenne muscular dystrophy (DMD) and rhabdomyosarcomasGenetic Mechanisms
14
Aslanidi (George) Molecular Bioengineering and Cancer Vaccinegaslanid@umn.eduGeorge Aslanidi, PhD
Research & Innovation Office
The Hormel Institute Viral vectors, AAV, gene therapy, cancer vaccineGenetic Mechanisms
15
Azarin (Samira) Research Group azarin@umn.eduSamira Azarin, PhDScience and EngineeringChemical Engineering and Materials Sciencestem cell engineering and development of systems to study and control breast cancer progression and metastasis. I am interested in elucidating mechanisms of dormancy and activation in disseminated breast cancer cellsImmunology
16
Bailey (Zinzi) [lead]zbailey@umn.eduZinzi Bailey, ScD, MSPHPublic HealthEpidemiology and Community Healthlung and gynecological cancer disparities across the cancer continuum"Screening, Prevention, Etiology and Cancer Survivorship"
17
Balbo (Silvia) Research Groupbalbo006@umn.eduSilvia Balbo, PhD Public HealthEnvironmental Health Sciencesinteraction of DNA and chemicals to investigate how lifestyle and environment exposures cause diseaseCarcinogenesis and Chemoprevention
18
Bartolomucci (Alessandro) Laboratory abartolo@umn.eduAlessandro Bartolomucci, PhD Medical SchoolIntegrative Biology and Physiologyintegrative approach to animal patho-physiology which combines state-of-the-art in vivo models with cellular models and molecular techniquesCarcinogenesis and ChemopreventionAnimal Models for the Social Dimension of Health and Aging Research Network
19
Batchelor (Eric) Labebatchel@umn.eduEric Batchelor , PhDMedical SchoolCellular Mechanisms
20
Bazurto (Jannell) Labjbazurto@umn.eduJannell Bazurto, PhDBiological SciencesPlant and Microbial Sciencesformaldehyde-induced cell damage and formaldehyde stress response in a model bacterium with a formaldehyde-centric metabolism where formaldehyde is an obligate central intermediate that is maintained in millimolar concentrationsCarcinogenesis and Chemoprevention
21
Bazzaro (Martina) Labmbazzaro@umn.eduMartina Bazzaro, PhDMedical SchoolObstetrics, Gynecology and Women's Healthtargeted therapies based on inhibition of proteolytic pathways in the treatment of both ovarian and cervical cancerCellular Mechanisms
22
Beckman (Joan) Labbeckm092@umn.eduJoan Beckman, MD, PhDMedical SchoolMedicinemechanisms of bleeding and thrombosis in patients with malignanciesCellular Mechanisms
23
Belcher (John) Labbelcher@umn.eduJohn Belcher, PhDMedical SchoolMedicinecell signaling pathways promoting innate immune toll-like receptor and complement-mediated signaling and the countervailing anti-inflammatory pathways that oppose innate immune inflammation in hematologic diseasesCellular Mechanisms
24
Bemis (Lynne) Lab ltbemis@umn.eduLynne Bemis, PhDMedical School, Duluth CampusMedical School, Duluth Campusdeep sequencing of urine biomarkers for ovarian cancer, extracellular RNA and exosomes in melanoma, brain tumors and ovarian cancer.Genetic Mechanisms
25
Biostatistics Shared ResourceJ. Sunil RaoJ. Sunil Rao, PhD ​
26
Blaes (Anne) [lead]Anne BlaesAnne Blaes, MDMedical SchoolMedicinecancer survivorship, the late effects of cancer therapy, and medical education"Screening, Prevention, Etiology and Cancer Survivorship"
27
Blazar (Bruce) Laboratory blaza001@umn.eduBruce Blazar, MDMedical SchoolPediatricsBMT: graft-versus-host disease, graft-versus-leukemia, BMT - mouse/human tumor immunotherapyTransplant and Cellular Therapy
28
Blood Bank Laboratorycscohn@umn.eduClaudia Cohn, MD, PhD Medical SchoolLaboratory Medicine and PathologyTransmission of infectious disease via donor stem cell product to patients receiving hematopoietic stem cell transplant; the recovering immune system in engrafted transplant patients; mechanisms of tolerance & accommodation in solid organ transplantTransplant and Cellular Therapy
29
Bode (Anne) Cancer Biomarkers and Drug Resistance bodex008@umn.eduAnn Bode, PhD
Research & Innovation Office
The Hormel InstituteMolecular and cellular biology of cancer developmentCarcinogenesis and Chemoprevention
30
Boehnke (Natalie) Research Groupnboehnke@umn.eduNatalie Boehnke, PhDScience and EngineeringChemical Engineering and Materials Scienceimproving the fundamental understanding of nanoparticle properties and their interactions with the biological environment to rationally address unmet needs in cancer treatmentCellular Mechanisms
31
Bolan (Patrick) Labbola0035@umn.eduPatrick Bolan, PhDMedical SchoolRadiologytechniques for magnetic resonance imaging and spectroscopy of breast cancer, and evaluating their efficacy for diagnosing suspect lesions and monitoring response to chemotherapyCellular Mechanisms
32
Boris-Lawrie (Kathleen) Retrovirus and RNA BiologyKathleen Boris-LawrieKathleen Boris-Lawrie, PhDVeterinary MedicineVeterinary and Biomedical SciencesRetroviruses that cause cancer and AIDS; stress-regulated translation control; noncoding RNA and epitranscriptomics; bioinformatic, genomic and proteomic approaches; biophysical, molecular and structural biology tools; transdisciplinary teamsGenetic MechanismsHost-Pathogen Interface biology
33
Bosnakovski (Darko) Lab darko@umn.eduDarko Bosnakovski, DVM, PhDMedical SchoolPediatricsUnderstanding molecular mechanisms by which oncogenes with pioneer transcription activity induce epigenetic modification, which leads to malignant transformationCellular Mechanisms
34
Bushnell (Grace) Oncomaterials Research Group (ORG)ggb@umn.eduGrace Bushnell, PhDScience and EngineeringBiomedical Engineeringbreast cancer dormancy, using biomaterials and immune-competent models to explore immune regulation of dormancy and identify therapeutic targets to prevent metastatic recurrenceCellular Mechanisms
35
Camell (Christina) Labccamell@umn.eduChristina Camell, PhDMedical SchoolBiochemistry, Molecular Biology, and Biophysicsinflammation and immunosenescence, using mouse models and a wide range of techniques to investigate the cellular and molecular mechanisms. With Dr. Beshay Zordoky, we have projects investigating chemotherapy-induced immunosenescenceImmunology
36
Campbell (Colin) Labcampb034@umn.eduColin Campbell, PhDMedical SchoolPharmacologyunderstanding the repair of DNA damage induced by bifunctional alkylating agents. We are also interested in the molecular etiology of cancer and associated DNA repair defects observed in cells from patients with Fanconi anemiaGenetic Mechanisms
37
Cancer Bioengineering InitiativeOur teamDavid Odde, PhD and Paolo Provenzano, PhDvariousvariousDoubling the success rate of cancer trials through engineeringCellular MechanismsCancer Bioengineering Initiative
38
Cancer Bioinformatics Shared Resourcewangjh@umn.eduJinhua Wang, PhDOffice of Academic and Clinical AffairsBioMedical Health InformaticsComputational analysis of high-throughput cancer genomics data especially as it relates to high-throughput data mining and modeling, heterogeneous genomics data integration, comparative genomics, integrating copy number variation, gene expression profiling, sequence somatic mutations and proteomic data, and novel methods development.Unaffilliated
39
Cancer Genomics Shared Resourcehirsc003@umn.eduBetsy Hirsch, PhDMedical SchoolLaboratory Medicine and Pathologychromosomal instability disorders; inherited conditions which predispose to the development of malignancy (e.g. Fanconi anemia, ataxia telangiectasia, Bloom syndrome)Unaffilliated
40
Cancer Genomics Shared Resourcekbeckman@umn.eduKenny Beckman, PhD Genomics CenterBiomedical GenomicsCancer Genomics Shared Resource Co-DirectorGenetic Mechanisms
41
Cancer Informatics Shared ResourceSteve JohnsonSteve Johnson, PhD​
42
Cancer Research Translational Initiative (CRTI)​
43
Carlson (Cathy) [lead]carls099@umn.eduCathy Carlson, DVM, PhD, DACVPVeterinary MedicineVeterinary Population Medicineinterpretation of neoplastic leasions in animal modelsUnaffilliated
44
Carroll (Dana) [lead]dcarroll@umn.eduDana Carroll, PhD, MPHPublic HealthEnvironmental Health Sciencesepidemiologist committed to reducing health disparities driven by commercial tobacco use. Recently I have been working with American Indian communities on developing personalized and cultural-tailored approaches to smoking cessation"Screening, Prevention, Etiology and Cancer Survivorship"
45
Chen (Liam) Neuropathology & IHC Laboratoryllchen@umn.eduLiam Chen, MD, PhDMedical SchoolNeuropathologyCNS tumor, including its neuropathology and molecular pathology aspectsGenetic Mechanisms
46
Clarke (Duncan) LabDuncan ClarkeDuncan Clarke, PhDBiological SciencesGenetics, Cell Biology, and Development
mechanisms that dictate faithful genome transmission​
47
Clinical Trials Office (CTO)Melissa Geller, MD​
48
Cognitive Artificial Intelligence Research Lab (CAIR) martinm@umn.eduMartin Michalowski, PhD, FAMIANursingPopulation Health and SystemsInformation integration, heuristic-based planning, constraint satisfaction problems, and my research brings advanced artificial intelligence methods to clinical decision support at the point of care and to personalized medicineTransplant and Cellular Therapy
49
Cognitive Artificial Intelligence Research Lab (CAIR) kotly001@umn.eduMichael Kotlyar, PharmDPharmacyExperimental and Clinical Pharmacologya) how various pharmocotherapies affect smoking behavior b) the relationship between smoking and stress response and c) the effect of psychiatric pharmacotherapy on the physiologic response to mental stress"Screening, Prevention, Etiology and Cancer Survivorship"
50
Comparative and Molecular Biosciences (various)Veterinary Medicine​
51
Comparative Pathology Shared Resourcedseelig@umn.eduDavis Seelig, DVM, PhD, ACVPVeterinary MedicineVeterinary Clinical SciencesComparative neuropathology with interest in brain bystander effects of cancer treatment (principally radiation).Genetic Mechanisms
52
Coordinating Centers for Biometric Research (CCBR)reill017@umn.eduCavan Reilly, PhDPublic HealthBiostatistics and Health Data Sciencegenetic transmission of cancer risk"Screening, Prevention, Etiology and Cancer Survivorship"
53
Data Science and AI Hub (DSAI Hub)Genevieve Melton-MeauxGenevieve Melton-Meaux, MD, PhDTransplant and Cellular Therapy
54
Davydova (Julia) Labdavyd003@umn.eduJulia Davydova, MD, PhDMedical SchoolSurgerydevelopment of new oncolytic-virus based therapeutic and imaging modalities for pancreatic cancer, combination of oncolytic virus with immunotherapy and/or chemo-radiation to establish effective therapies for treatment-resistant cancer, and development of in vivo cancer modelsGenetic MechanismsImpact Surgery
55
Debes (Jose) Labdebes003@umn.eduJose Debes, MD, MSMedical SchoolMedicineProgression of viral hepatitis to hCC; Biomarkers for HCC in South America; Interplay between HBV and HCC in AfricaGenetic Mechanisms
56
Dehm (Scott) Labdehm@umn.eduScott Dehm, PhDMedical SchoolLaboratory Medicine and PathologyAndrogen receptor & prostate cancerCellular MechanismsResearch Video
57
Dickerson (Erin) Labedickers@umn.eduErin Dickerson, PhDVeterinary MedicineVeterinary Clinical SciencesDevelopment of peptides as novel anti-cancer agents for ovarian cancer. Creation of bifunctional peptide/cytokine reagents as unique targeting combinations. Peptide targeted delivery of nanoparticles and their payloadsCellular Mechanisms
58
Distefano (Mark) Research Groupdiste001@umn.eduMark Distefano, PhDScience and EngineeringChemistryprotein prenylationCarcinogenesis and Chemoprevention
59
Dong (Xiao) Laboratorydong0265@umn.eduXiao DongBiological Sciencescausal mechanisms of human agingGenetic Mechanisms
60
Dorr (Casey) Labdorr0022@umn.eduCasey Dorr, PhDMedical SchoolMedicinemolecular and cellular mechanisms of kidney allograft loss with spatialomics, genomics, transcriptomics and clinical outcomes data. We also use pharmacogenomics to develop personalize medicine through cell culture assaysGenetic Mechanisms
61
Drake (Justin) [lead]jdrake@umn.eduJustin Drake, PhDMedical SchoolPharmacologySignaling networks in lethal metastatic castration resistant prostate cancerCellular MechanismsResearch Video
62
Duluth Global Health Research Institute malabsi@umn.eduMustafa al'Absi, PhDMedical School, Duluth CampusMedical School, Duluth CampusExamining behavioral and psychobiological risk factors of cigarette smoking and stress"Screening, Prevention, Etiology and Cancer Survivorship"
63
Ebbini (Emad) Ultrasound Imaging and Signal Processing Labemad@umn.eduEmad Ebbini, PhD Science and EngineeringElectrical and Computer Engineeringimaging and therapy with ultrasound phased-array systems.Cellular Mechanisms
64
Eli Coleman Institute for Sexual and Gender Health (primary group)Abby GirardAbby Girard, PsyD, LMFT
Medical SchoolFamily Medicine and Community Health​
65
Elmquist (William) Labelmqu011@umn.eduWilliam Elmquist, PharmD, PhDPharmacyPharmaceuticsPharmacokinetics, Membrane transporters, CNS drug deliveryCellular Mechanisms
66
Engelhart (Aaron) LaboratoryAaron EngelhartAaron Engelhart, PhDBiological SciencesGenetics, Cell Biology, and Development
Engineering RNA-based tools to probe and manipulate biological systemsGenetic Mechanisms
67
Experimental and Clinical Pharmacology (ECP)Robert StrakaRobert J. Straka, PharmD, FCCP PharmacyExperimental and Clinical Pharmacology"Screening, Prevention, Etiology and Cancer Survivorship"
68
Farrar (Michael) Labfarra005@umn.eduMichael Farrar, PhDMedical SchoolLaboratory Medicine and Pathologymechanisms by which the serine/threonine kinase Rof is activated and on the role that the Ras/Rof pathway plays in regulating lymphocyte developmentImmunologyResearch Video
69
Ferguson (David) Research Group ferguson@umn.eduDavid Ferguson, PhDPharmacyMedicinal ChemistryTherapeutic development with an emphasis on DNA binding agents that disrupt topoisomerase function in cell proliferationCarcinogenesis and Chemoprevention
70
Ferreira (Clara) Brachytherapy Research Labcferreir@umn.eduClara Ferreira, PhDMedical SchoolRadiation OncologyRadiation Therapy outcomes, Permanent Radioactive Brain implants, Treatment outcomes, health disparities, gyn brachytherapy, ocular brachytherapy"Screening, Prevention, Etiology and Cancer Survivorship"
71
Fife (Brian) Labbfife@umn.eduBrian Fife, PhDMedical SchoolMedicinebiology of the CTLA-4 and PD-1 pathways, and applying novel methods to deliver signals through these pathways to control autoimmunity, prevent transplanted tissue rejection and eliminate tumorsImmunology
72
Flow Cytometry Shared Resourceflowsort Flow Cytometry Core Facility Sortingflowcytometry.umn.edu​
73
Foo Lab - Cancer progressionJasmine FooJasmine Foo, PhDScience and EngineeringMathematicsCellular progressionGenetic Mechanisms
74
Freedman (Tanya) Labtfreedma@umn.eduTanya Freedman, PhDMedical SchoolPharmacologyhow inflammation modulates macrophage responsiveness, including in the inflammatory tumormicroenvironment, especially in breast cancer. We also investigate regulation of proto-oncogenic signaling proteins like the Src family kinasesImmunologyResearch Video
75
Freeman (Michael) LabMichael FreemanMichael Freeman, PhDBiological SciencesBiochemistry, Molecular Biology, and BiophysicsNatural product biosynthesis | Microbial genetics | Targeted metagenomics
Carcinogenesis and Chemoprevention
76
French (Jerrod) Nucleotide Metabolism & Drug Discovery jfrench@umn.eduJarrod French, PhD
Research & Innovation Office
The Hormel Instituteregulation of nucleotide metabolism in humansCellular Mechanisms
77
Furcht (Leo) [lead]furch001@umn.eduLeo Furcht, MDMedical SchoolLab Medicine and Pathologyextracellular matrix, metastasis, wound healingCellular Mechanisms
78
Gardner (Melissa) Labklei0091@umn.eduMelissa Gardner, PhDBiological SciencesGenetics, Cell Biology and Developmentexperimental and computational approach to dissect molecular mechanisms for how cells divide, and for how cell division can be controlled to prevent genetic diseases, pathogenic anti-fungal drug resistance, and cancerGenetic Mechanisms
79
Geller (Melissa) [lead]Melissa Geller, MDMelissa Geller, MDMedical SchoolObstetrics, Gynecology and Women's Healthworks a lot with the Miller LabTransplant and Cellular Therapy
80
Genome Engineering Shared Resourcegesr University of MinnesotaBeau Webber Branden Moriarity​
81
Georg (Gunda I.) Research Groupgeorg@umn.eduGunda Georg, PhDPharmacyMedicinal ChemistryMedicinal chemistry; design, synthesis, and evaluation of synthetic and natural product-derived anticancer agents; drug discovery by HTSCellular Mechanisms
82
Giubellino (Alessio) Labagiubell@umn.eduAlessio Giubellino, MD, PhDMedical SchoolLaboratory Medicine and Pathologyunderstanding the molecular mechanisms and signaling pathways in melanoma with the goal of developing predictive biomarkers and combination therapies for the diseaseCellular Mechanisms
83
Goldstrohm (Aaron) Labagoldstr@umn.eduAaron Goldstrohm, PhDBiological SciencesBiochemistry, Molecular Biology, and BiophysicsRegulation of gene expression by RNA-binding proteins and ribonucleases, and their roles in developmental biology and human disease.Genetic Mechanisms
84
Gopalakrishnan & Koutlas Oral Pathology Laboratorykoutl001@umn.eduIoannis Koutlas, DDS, MSDentistryDiagnostic and Biological ScienceMutation analysis, clonality analysis, gene therapyGenetic Mechanisms
85
Gopalakrishnan & Koutlas Oral Pathology Laboratorygopal007@umn.eduRajaram Gopalakrishnan, BDS, PhDDentistryDiagnostic and Biological Sciencesignaling & transcriptional control mechanisms regulating genes involved in bone mineralization.Carcinogenesis and Chemoprevention
86
Gopalakrishnan & Koutlas Oral Pathology LaboratoryZachary Davis PhDZach Davis, PhDMedical SchoolMedicine​
87
Gordon (Peter) Labgord0047@umn.eduPeter Gordon, MD, PhDMedical SchoolPediatrics i) developing approaches for overcoming bone marrow stromal cell mediated chemoresistance in AML and ii) how factors secreted by cells within the leukemia microenvironment impact leukemia development and response to therapyCellular Mechanisms
88
Gordon (Wendy) Labwrgordon@umn.eduWendy Gordon, PhDBiological SciencesBiochemistry, Molecular Biology, and Biophysicsmolecular mechanisms of how cells sense and respond to mechanical forces. We also develop tools to allow high-throughput readouts of cellular mechanical phenotypes to identify mechanosensors that drive malignant mechanotypesCellular Mechanisms
89
Gradilone (Sergio) Cancer Cell Biology & Translational Researchsgradilo@umn.eduSergio Gradilone, PhD
Research & Innovation Office
The Hormel InstituteTumor cell biology and translational research, Primary cilia in tumor biologyCellular Mechanisms
90
Griffin (Timothy) Center for Metabolomics and Proteomicstgriffin@umn.eduTimothy GriffinBiological SciencesBiochemistry, Molecular Biology, and BiophysicsGenetic Mechanisms
91
Griffith (Thomas) Labtgriffit@umn.eduThomas Griffith, PhDMedical SchoolUrologyTumor immunology, apoptosisImmunology
92
Guinovart (David) Mathematical, Computational, and Statistical Modelingguino001@umn.eduDavid Guinovart, PhD
Research & Innovation Office
The Hormel Instituteapplied mathematics, focusing on mathematical modeling in biomedicine, including cancer, nutrition, cell proliferation, and epidemiology, to provide insights and solutions in these areasCellular Mechanisms
93
Gurvich (Vadim) GMP Manufacturing Services vadimg@umn.eduVadim Gurvich, PhD, MBAPharmacyMedicinal ChemistryOrganic and medicinal chemistry; synthesis of carcinogenic agents; PAH-DNA adduction; chemical process development; synthesis of anti-cancer agents for pre-clinical and clinical applicationsCarcinogenesis and Chemoprevention
94
Hackel (Benjamin) Research Group hackel@umn.eduBenjamin Hackel, PhDScience and EngineeringChemical Engineering and Materials Scienceprotein engineering to molecular imaging to enable detection and characterization of cancerCellular Mechanisms
95
Hafenstein (Susan)- Cryogenic-Sample Electron Microscopy (CryoEM)hafen@umn.eduSusan Hafenstein, PhD
Research & Innovation Office
The Hormel Institutehuman papillomavirus using a structural approach. The research focus is mechanisms of cellular entry and location and structure of the highly conserved minor structural protein, L2Genetic Mechanisms
96
Hamilton-Hart (Sara) Labhamil062@umn.eduSara Hamilton Hart, PhDMedical SchoolLaboratory Medicine and PathologyCD8 T cell activation, T cell memory generation and maintenance, enhance protective immunity, inhibiting T cell pathologyImmunology
97
Harki (Daniel) Laboratorydaharki@umn.eduDaniel Harki, PhDPharmacyMedicinal Chemistrysynthesis and characterization of small molecules that influence cellular function. We are particularly interested in reactive natural products and analogues, and modified nucleosides as potential anticancer agentsCellular Mechanisms
98
Harris (Reuben) LabReuben HarrisReuben Harris, PhDOffice of Academic Clinical AffairsInstitute for Health InformaticsHHMI investigator, is a leading cancer and HIV research facility(Not a member)
99
Hart (Geoffrey) [lead]hart0792@umn.eduGeoffrey Hart, PhDMedical SchoolMedicineinnate immunity, particularly NK cells and antibody dependent cellular cytotoxicity (ADCC)ImmunologyGeoffrey T Hart
100
Hatsukami (Dorothy) [lead]hatsu001@umn.eduDorothy Hatsukami, PhDMedical SchoolPsychiatrycharacterization and treatment of nicotine dependence; treatment of special populations including women, adolescents and spit tobacco users"Screening, Prevention, Etiology and Cancer Survivorship"